Atul Mukund Deshpande
Nessuna posizione attualmente
Profilo
Atul Mukund Deshpande worked as an Associate Director at Sanofi, Inc. (China) from 2012 to 2014 and as an Executive Director & Chief Strategy Officer at HBM Holdings Ltd.
from 2018 to 2021.
He earned a doctorate degree from the University of California, Irvine in 2007, an MBA from Cranfield University in 2011, and an undergraduate degree from the University of Mumbai in 2000.
Precedenti posizioni note di Atul Mukund Deshpande
| Società | Posizione | Fine |
|---|---|---|
| HBM HOLDINGS LIMITED | Director/Board Member | 25/04/2021 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01/12/2014 |
Formazione di Atul Mukund Deshpande
| University of California, Irvine | Doctorate Degree |
| Cranfield University | Masters Business Admin |
| University of Mumbai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The private company is based in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Atul Mukund Deshpande
